Federated Nordic cohorts
An architectural choice between a parallel KISO-style national prospective cohort and a shared Nordic prospective cohort with country-specific arms.
Rather than building a new cohort from scratch, this federates existing assets (MoBa 100K+, NSHDS 140K+) and enriches them with hormonal and reproductive data. The result: complete health trajectory tracking from adolescence through menopause — a capability not possible anywhere else.
Transformation
From
The cross-Nordic federation through the NordForsk Nordic Biobank Network (2026–2030) draws on registry-linked depth, but prospective collection of menstrual, hormonal, and reproductive life-stage variables sits only in Denmark (KISO, Aarhus 300k) at population scale
To
A collective architectural choice between a parallel national prospective cohort modelled on KISO methodology and a shared Nordic prospective cohort with country-specific arms — letting life-stage data join genetic, register, and biobank data within a federated infrastructure that becomes the global reference for women's health longitudinal research
Description
Nordic women’s health research becomes legible at scale through prospective and register-linked longitudinal populations, including MoBa, NSHDS, the Danish biobank, FinnGen, deCODE, their federated successors, and new cohorts purpose-built for women’s life-stage data.
The cross-Nordic federation being established through the 2026 to 2030 NordForsk Nordic Biobank Network draws on the registry-linked depth that makes the Nordics distinctive for women’s health research. The missing piece is the prospective collection of menstrual, hormonal, and reproductive life-stage variables outside Denmark, where KISO and Aarhus 300k are currently the only cohorts doing so at a population scale. Two routes are open: a parallel national prospective cohort modelled on KISO methodology, or a shared Nordic prospective cohort with country-specific arms. The choice is best made collectively rather than nationally, and either would allow life-stage data to join genetic, register, and biobank data within a federated infrastructure, making Nordic cohort science the global reference for women’s health longitudinal research. The cohort PIs in dialogue, with NordForsk as funder, are positioned to make the architectural choice.
Evidence anchors
At a glance
- Natural lead
- Cohort PIs in dialogue, with NordForsk as funder, positioned to make the architectural choice
- Indicative investment
- €5–10M over enrichment phase
Entry points
- NordicNordForsk coordinates federation governance
- NationalCohort stewards agree enrichment protocols
- RegionalUniversity hospitals contribute clinical data linkage
Indicators
Output
- Federation governance agreed; enrichment protocol designed
- 3+ cohorts enriched with WH variables
- Federated cohort established as permanent infrastructure
Handoff
- Data Dictionary (R-D-1) standards adopted for enrichment
- Intelligence Layer (I-D-1) trained on federated data
- Care guidelines (C-Po-1) reference federated cohort evidence
Outcome
- Enrichment pilot data available
- Novel findings from registry-linked WH data
Building on
Connected needs
Cite this need
Cite this need
Persson, J. (2026). R-D-2 Federated Nordic cohorts. In The Nordic Implementation Playbook for Women's Health 2040. CIFS. https://womenshealth2040.org/playbook#r-d-2